1
|
Maranki JL, Schwaitzberg SD, Sharaiha RZ, Kushnir VM, Badurdeen DS, Kumbhari V, Gómez V, Kumta NA, Waye JD, Nieto J, Ujiki MB, Benias PC, Miller LS, Kedia P, Tarnasky P, Mathew A, Levenick JM, Inamdar S, Tharian B, Nersesova Y, Fredell L, Serra S, Kochman ML. Challenges of developing and executing a multi-site registry for a novel device with evolving indications for use. Surg Endosc 2022; 36:9123-9128. [PMID: 35920904 PMCID: PMC9362130 DOI: 10.1007/s00464-022-09392-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2022] [Accepted: 06/06/2022] [Indexed: 01/06/2023]
Abstract
BACKGROUND The introduction of new technologies in endoscopy has been met with uncertainty, skepticism, and lack of standardization or training parameters, particularly when disruptive devices or techniques are involved. The widespread availability of a novel endoscopic suturing device (OverStitch™) for tissue apposition has enabled the development of applications of endoscopic suturing. METHODS The American Gastroenterological Association partnered with Apollo Endosurgery to develop a registry to capture in a pragmatic non-randomized study the safety, effectiveness, and durability of endoscopic suturing in approximating tissue in the setting of bariatric revision and fixation of endoprosthetic devices. RESULTS We highlight the challenges of the adoption of novel techniques by examining the process of developing and executing this multicenter registry to assess real-world use of this endoscopic suturing device. We also present our preliminary data on the safety and effectiveness of the novel device as it is applied in the treatment of obesity. CONCLUSIONS The Prospective Registry for Trans-Orifice Endoscopic Suturing Applications (ES Registry) was an effective Phase 4, postmarketing registry aimed at capturing pragmatic, real-world use of a novel device. These findings serve to solidify the role of endoscopic suturing in clinical practice.
Collapse
Affiliation(s)
- Jennifer L Maranki
- Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Hershey Medical Center, Hershey, PA, USA.
| | | | - Reem Z Sharaiha
- Gastroenterology Division, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA
| | - Vladimir M Kushnir
- Division of Gastroenterology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA
| | - Dilhana S Badurdeen
- Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA
| | - Vivek Kumbhari
- Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL, USA
| | - Victoria Gómez
- Division of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL, USA
| | - Nikhil A Kumta
- Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Jerome D Waye
- Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Jose Nieto
- Division of Gastroenterology, Borland-Groover Clinic, Jacksonville, FL, USA
| | - Michael B Ujiki
- Division of Gastrointestinal and General Surgery, NorthShore University Health System, Department of Surgery, Pritzker School of Medicine, University of Chicago, Chicago, IL, USA
| | - Petros C Benias
- Division of Gastroenterology, Lenox Hill Hospital, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New York, NY, USA
| | - Larry S Miller
- Division of Gastroenterology, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, Manhasset, NY, USA
| | | | | | - Abraham Mathew
- Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Hershey Medical Center, Hershey, PA, USA
| | - John M Levenick
- Division of Gastroenterology and Hepatology, Department of Medicine, Penn State Hershey Medical Center, Hershey, PA, USA
| | - Sumant Inamdar
- University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | - Benjamin Tharian
- University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | | | - Lydia Fredell
- American Gastroenterological Association, Bethesda, MD, USA
| | - Sonya Serra
- American Gastroenterological Association, Bethesda, MD, USA
| | - Michael L Kochman
- Center for Endoscopic Innovation, Research, and Training, Gastroenterology Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
2
|
Kelly CR, Yen EF, Grinspan AM, Kahn SA, Atreja A, Lewis JD, Moore TA, Rubin DT, Kim AM, Serra S, Nersesova Y, Fredell L, Hunsicker D, McDonald D, Knight R, Allegretti JR, Pekow J, Absah I, Hsu R, Vincent J, Khanna S, Tangen L, Crawford CV, Mattar MC, Chen LA, Fischer M, Arsenescu RI, Feuerstadt P, Goldstein J, Kerman D, Ehrlich AC, Wu GD, Laine L. Fecal Microbiota Transplantation Is Highly Effective in Real-World Practice: Initial Results From the FMT National Registry. Gastroenterology 2021; 160:183-192.e3. [PMID: 33011173 PMCID: PMC8034505 DOI: 10.1053/j.gastro.2020.09.038] [Citation(s) in RCA: 94] [Impact Index Per Article: 31.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/01/2020] [Revised: 08/26/2020] [Accepted: 09/24/2020] [Indexed: 02/08/2023]
Abstract
BACKGROUND & AIMS Fecal microbiota transplantation (FMT) is used commonly for treatment of Clostridioides difficile infections (CDIs), although prospective safety data are limited and real-world FMT practice and outcomes are not well described. The FMT National Registry was designed to assess FMT methods and both safety and effectiveness outcomes from North American FMT providers. METHODS Patients undergoing FMT in clinical practices across North America were eligible. Participating investigators enter de-identified data into an online platform, including FMT protocol, baseline patient characteristics, CDI cure and recurrence, and short and long-term safety outcomes. RESULTS Of the first 259 participants enrolled at 20 sites, 222 had completed short-term follow-up at 1 month and 123 had follow-up to 6 months; 171 (66%) were female. All FMTs were done for CDI and 249 (96%) used an unknown donor (eg, stool bank). One-month cure occurred in 200 patients (90%); of these, 197 (98%) received only 1 FMT. Among 112 patients with initial cure who were followed to 6 months, 4 (4%) had CDI recurrence. Severe symptoms reported within 1-month of FMT included diarrhea (n = 5 [2%]) and abdominal pain (n = 4 [2%]); 3 patients (1%) had hospitalizations possibly related to FMT. At 6 months, new diagnoses of irritable bowel syndrome were made in 2 patients (1%) and inflammatory bowel disease in 2 patients (1%). CONCLUSIONS This prospective real-world study demonstrated high effectiveness of FMT for CDI with a good safety profile. Assessment of new conditions at long-term follow-up is planned as this registry grows and will be important for determining the full safety profile of FMT.
Collapse
Affiliation(s)
- Colleen R. Kelly
- Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island
| | - Eugene F. Yen
- Division of Gastroenterology, NorthShore University HealthSystem, Evanston, Illinois
| | - Ari M. Grinspan
- Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York
| | - Stacy A. Kahn
- Division of Gastroenterology, Hepatology and Nutrition, Boston Children’s Hospital, Boston, Massachusetts
| | - Ashish Atreja
- Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York
| | - James D. Lewis
- Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | | | - David T. Rubin
- Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago Medicine, Chicago, Illinois
| | - Alison M. Kim
- American Gastroenterological Association, Bethesda, Maryland
| | - Sonya Serra
- American Gastroenterological Association, Bethesda, Maryland
| | | | - Lydia Fredell
- American Gastroenterological Association, Bethesda, Maryland
| | | | - Daniel McDonald
- Department of Pediatrics, University of California San Diego, La Jolla, California
| | - Rob Knight
- Department of Pediatrics, University of California San Diego, La Jolla, California,Center for Microbiome Innovation, University of California San Diego, La Jolla, California,Department of Computer Science and Engineering, University of California San Diego, La Jolla, California,Department of Bioengineering, University of California San Diego, La Jolla, California
| | | | - Joel Pekow
- Section of Gastroenterology, Hepatology, and Nutrition, University of Chicago Medicine, Chicago, Illinois
| | - Imad Absah
- Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Ronald Hsu
- Sutter Health, Sutter Institute for Medical Research and Division of Gastroenterology, School of Medicine, University of California, Davis, California
| | - Jennifer Vincent
- Division of Gastroenterology, Baylor Scott and White Research Institute, Temple, Texas
| | - Sahil Khanna
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Lyn Tangen
- Carle Foundation Hospital, Urbana, Illinois
| | - Carl V. Crawford
- Division of Gastroenterology, Weill Cornell Medicine, New York, New York
| | - Mark C. Mattar
- Division of Gastroenterology, MedStar Georgetown University Hospital, Washington, District of Columbia
| | - Lea Ann Chen
- Division of Gastroenterology and Hepatology, New York University Grossman School of Medicine, New York, New York
| | - Monika Fischer
- Division of Gastroenterology, Indiana University, Indianapolis, Indiana
| | - Razvan I. Arsenescu
- Atlantic Inflammatory Bowel Disease Center of Excellence, Atlantic Digestive Health Institute, Morristown, New Jersey
| | | | | | - David Kerman
- Division of Gastroenterology, University of Miami Miller School of Medicine, Miami, Florida
| | - Adam C. Ehrlich
- Section of Gastroenterology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania
| | - Gary D. Wu
- Division of Gastroenterology and Hepatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Loren Laine
- Yale School of Medicine, New Haven, Connecticut,Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut
| |
Collapse
|